Vitamin D, an essential nutrient with versatile functions in nearly all organs

International Journal for Vitamin and Nutrition Research

Volumn 83, Issue 2, 2013, Pages 92-100

  Stöcklin, Elisabeth ^a   Eggersdorfer, Manfred ^a  

^a DSM NUTRITIONAL PRODUCTS LTD   (Switzerland)

Author keywords

Falls; Fractures; Health benefits; Recommendations; vitamin D; Vitamin D deficiency

Indexed keywords

CALCITRIOL; OXYGENASE; PARATHYROID HORMONE; VITAMIN D; VITAMIN D RECEPTOR;

ADVERSE OUTCOME; ARTICLE; BIOLOGICAL ACTIVITY; BONE MINERALIZATION; CALCIUM HOMEOSTASIS; DRUG SAFETY; FRACTURE; HUMAN; HYPERCALCEMIA; HYPERCALCIURIA; KIDNEY CALCIFICATION; NEUROMUSCULAR FUNCTION; OSTEOGENESIS IMPERFECTA; OSTEOPOROSIS; RECOMMENDED DRUG DOSE; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN D METABOLISM; VITAMIN SUPPLEMENTATION;

FALLS; FRACTURES; HEALTH BENEFITS; RECOMMENDATIONS; VITAMIN D; VITAMIN D DEFICIENCY;

FRACTURES, BONE; HUMANS; NUTRITIONAL REQUIREMENTS; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84894330238     PISSN: 03009831     EISSN: 16642821     Source Type: Journal    
DOI: 10.1024/0300-9831/a000151     Document Type: Article

References (98)

1. Prentice, A. (2008) Vitamin D deficiency: a global perspective. Nutr. Rev. 66, S153-1642.
2. Ginde, A.A., Liu, M.C., Camargo and C.A., Jr. (2009) Demographic differences and trends of vitamin D insufficiency in the US population, 1988-2004. Arch. Intern. Med. 169, 626-632.
3. Holick, M.F. (2007) Vitamin D deficiency. N. Engl. J. Med. 357, 266-281.
4. IOM (2011) Dietary Reference Intakes for Calcium and Vitamin D. The National Academies Press, Washington, D.C.
5. DeLuca, H.F., Sicinski, R.R., Tanaka, Y., Stern, P.H. and Smith, C.M. (1988) Biological activity of 1,25-dihydroxyvitamin D2 and 24-epi-1,25-dihydroxyvitamin D2. Am. J. Physiol. 254, E402-406.
6. Haussler, M.R., Jurutka, P.W., Mizwicki, M. and Norman, A.W. (2011) Vitamin D receptor (VDR)- mediated actions of 1-alpha,25(OH)(2)vitamin D(3): genomic and non-genomic mechanisms. Best Pract. Res. Clin. Endocrinol. Metab. 25, 543-559.
7. Haussler, M.R., Whitfield, G.K., Kaneko, I. Haussler, C.A., Hsieh, D., Hsieh, J.C. and Jurutka, P.W. (2013) Molecular mechanisms of vitamin D action. Calcif. Tissue Int. 92, 77-98
8. Norman, A.W. and Bouillon, R. (2010) Vitamin D nutritional policy needs a vision for the future. Exp. Biol. Med. (Maywood) 235, 1034-1045.
9. Adams, J.S. and Hewison, M. (2010) Update in vitamin D. J. Clin. Endocrinol. Metab. 95, 471-478.
10. Holick, M.F. (2006) High prevalence of vitamin D inadequacy and implications for health. Mayo Clin. Proc. 81, 353-373.
11. Liu, P.T., Stenger, S., Li, H. et al. (2006) Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 311,1770-1773.
12. Schauber, J., Dorschner, R.A., Coda, A.B. et al. (2007) Injury enhances TLR2 function and antimicrobial peptide expression through a vitamin D-dependent mechanism. J. Clin. Invest. 117, 803-811.
13. Norman, A.W. (2006) Minireview: vitamin D receptor: new assignments for an already busy receptor. Endocrinology 147, 5542-5548.
14. Rosen, C.J., Adams, J.S., Bikle, D.D., Black, D.M., Demay, M.B., Manson, J.E., Murad, M.H. and Kovacs, C.S. (2012) The nonskeletal effects of vitamin D: an Endocrine Society scientific statement. Endocr. Rev. 33, 456-492.
15. Bouillon, R., Carmeliet, G., Verlinden, L., van Etten, E., Verstuyf, A., Luderer, H.F., Lieben, L., Mathieu, C. and Demay, M. (2008) Vitamin D and human health: lessons from vitamin D receptor null mice. Endocr. Rev. 29, 726-776.
16. Lanham-New S.A., Buttriss, J.L., Miles, L.M. et al. (2011) Proceedings of the Rank Forum on Vitamin D. Br. J. Nutr. 105, 144-156.
17. Heaney, R.P. and Holick, M.F. (2011) Why the IOM recommendations for vitamin D are deficient. J. Bone Miner. Res. 26, 455-457.
18. Vieth, R. (2011) Why the minimum desirable serum 25-hydroxyvitamin D level should be 75 nmol/L (30 ng/ml). Best Pract. Res. Clin. Endocrinol. Metab. 25, 681-691.
19. Hollis, B.W. (2011) Short-term and long-term consequences and concerns regarding valid assessment of vitamin D deficiency: comparison of recent food supplementation and clinical guidance reports. Curr. Opin. Clin. Nutr. Metab. Care 14, 598-604.
20. Thomas, M.K., Lloyd-Jones, D.M., Thadhani, R.I., Shaw, A.C., Deraska, D.J., Kitch, B.T., Vamvakas, E.C., Dick, I.M., Prince, R.L. and Finkelstein, J.S. (1998) Hypovitaminosis D in medical inpatients. N. Engl. J. Med. 338, 777-783.
21. Heaney, R.P. (2005) The Vitamin D requirement in health and disease. J. Steroid Biochem. Mol. Biol. 97, 13-19.
22. Heaney, R.P. (2013) What Is Vitamin D Insufficiency? And Does It Matter? Calcif. Tissue Int. 92(2): 177-83.
23. Priemel, M., von Domarus, C., Klatte, T.O. et al. (2010) Bone mineralization defects and vitamin D deficiency: histomorphometric analysis of iliac crest bone biopsies and circulating 25-hydroxyvitamin D in 675 patients. J. Bone Miner. Res. 25, 305-312.
24. Stockton, K.A., Mengersen, K., Paratz, J.D., Kandiah, D. and Bennell, K.L. (2011) Effect of vitamin D supplementation on muscle strength: a systematic review and meta-analysis. Osteoporos. Int. 22, 859-871.
25. Trivedi, D.P., Doll, R. and Khaw, K.T. (2003) Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial. BMJ 326, 469.
26. Bischoff-Ferrari, H.A., Shao, A., Dawson-Hughes, B., Hathcock, J., Giovannucci, E. and Willett, W.C. (2010) Benefit-risk assessment of vitamin D supplementation. Osteoporos. Int. 21, 1121-1132.
27. Autier, P. and Gandini, S. (2007) Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials. Arch. Intern. Med. 167, 1730-1737.
28. Melamed, M.L., Michos, E.D., Post, W. and Astor, B. (2008) 25-hydroxyvitamin D levels and the risk of mortality in the general population. Arch. Intern. Med. 168, 1629-1637.
29. Pilz, S., Iodice, S., Zittermann, A., Grant, W.B. and Gandini, S. (2011) Vitamin D status and mortality risk in CKD: a meta-analysis of prospective studies. Am. J. Kidney Dis. 58, 374-382.
30. Wang, T.J., Pencina, M.J., Booth, S.L., Jacques, P.F., Ingelsson, E., Lanier, K., Benjamin, E.J., D'Agostino, R.B., Wolf, M. and Vasan, R.S. (2008) Vitamin D deficiency and risk of cardiovascular disease. Circulation 117, 503-511.
31. Dawson-Hughes, B., Heaney, R.P., Holick, M.F., Lips, P., Meunier, P.J. and Vieth, R. (2005) Estimates of optimal vitamin D status. Osteoporos. Int. 16, 713-716.
32. Zittermann, A., Iodice, S., Pilz, S., Grant, W.B., Bagnardi, V. and Gandini, S. (2012) Vitamin D deficiency and mortality risk in the general population: a metaanalysis of prospective cohort studies. Am. J. Clin. Nutr. 95, 91-100.
33. Grant, W.B. (2011) An estimate of the global reduction in mortality rates through doubling vitamin D levels. Eur. J. Clin. Nutr. 65, 1016-1026.
34. Bischoff-Ferrari, H.A., Giovannucci, E., Willett, W.C., Dietrich, T. and Dawson-Hughes, B. (2006) Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am. J. Clin. Nutr. 84, 18-28.
35. van Schoor, N.M. and Lips, P. (2011) Worldwide vitamin D status. Best Pract. Res. Clin. Endocrinol. Metab. 25, 671-680.
36. Holick, M.F. (2006) Resurrection of vitamin D defi- ciency and rickets. J. Clin. Invest. 116,2062-2072.
37. Hypponen, E. and Power, C. (2007) Hypovitaminosis D in British adults at age 45 y: nationwide cohort study of dietary and lifestyle predictors. Am. J. Clin. Nutr. 85, 860-868.
38. Lips, P. (2010) Worldwide status of vitamin D nutrition. J. Steroid Biochem. Mol. Biol. 121, 297-300.
39. van der Meer, I.M., Middelkoop, B.J., Boeke, A.J. and Lips, P. (2011) Prevalence of vitamin D deficiency among Turkish, Moroccan, Indian and sub-Sahara African populations in Europe and their countries of origin: an overview. Osteoporos. Int. 22, 1009-1021.
40. Wahl, D.A., Cooper, C., Ebeling, P.R. et al. (2012) A global representation of vitamin D status in healthy populations. Arch. Osteoporos. 7, 155-172.
41. Mithal, A., Wahl, D.A., Bonjour, J.P., Burckhardt, P., Dawson-Hughes, B., Eisman, J.A., El-Hajj Fuleihan, G., Josse, R.G., Lips, P. and Morales-Torres, J. (2009) Global vitamin D status and determinants of hypovitaminosis D. Osteoporos. Int. 20, 1807-1820
42. Lips, P. (2007) Vitamin D status and nutrition in Europe and Asia. J. Steroid Biochem. Mol. Biol. 103, 620-625.
43. Looker, A.C., Pfeiffer, C.M., Lacher, D.A., Schleicher, R.L., Picciano, M.F. and Yetley, E.A. (2008) Serum 25-hydroxyvitamin D status of the US population: 1988-1994 compared with 2000-2004. Am. J. Clin. Nutr. 88, 1519-1527.
44. Holick, M.F. and Chen, T.C. (2008) Vitamin D defi- ciency: a worldwide problem with health consequences. Am. J. Clin. Nutr. 87, 1080S-1086S.
45. Doets, E.L., de Wit, L.S., Dhonukshe-Rutten, R.A. et al. (2008) Current micronutrient recommendations in Europe: towards understanding their differences and similarities. Eur. J. Nutr. 47 Suppl 1, 17-40.
46. Bischoff-Ferrari, H.A., Willett, W.C., Wong, J.B., Stuck, A.E., Staehelin, H.B., Orav, E.J., Thoma, A., Kiel, D.P. and Henschkowski, J. (2009) Prevention of nonvertebral fractures with oral vitamin D and dose dependency: a meta-analysis of randomized controlled trials. Arch. Intern. Med. 169, 551-561.
47. FDA (2008) FDA Updates Health Claim for Calcium and Osteoporosis. https://wwwfederalregistergov/articles/2008/09/29/E8-22730/food-labeling-healthclaims-calcium-and-osteoporosis-and-calciumvitamin-d-and-osteoporosis
48. Wagner, C.L. and Greer, F.R. (2008) Prevention of rickets and vitamin D deficiency in infants, children, and adolescents. Pediatrics 122, 1142-1152.
49. New Recommendations for vitamin D by the Nutrition Society (D A, CH) (2012) Die Referenzwerte für die Nährstoffzufuhr Vitamin D (D-A-CH Referenzwerte der DGE, ÖGE, SGE/SVE). http://wwwdgede/modulesphp?name=Content&pa=showpage&pid=4&page=12
50. Dawson-Hughes, B., Mithal, A., Bonjour, J.P., Boonen, S., Burckhardt, P., Fuleihan, G.E., Josse, R.G., Lips, P., Morales-Torres, J. and Yoshimura, N. (2010) IOF position statement: vitamin D recommendations for older adults. Osteoporos. Int. 21, 1151-1154.
51. Holick, M.F., Binkley, N.C., Bischoff-Ferrari, H.A., Gordon, C.M., Hanley, D.A., Heaney, R.P., Murad, M.H. and Weaver, C.M. (2011) Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J. Clin. Endocrinol. Metab. 96, 1911-1930.
52. Holick, M.F. (2012) Evidence-based D-bate on health benefits of vitamin D revisited. Dermatoendocrinol. 4, 183-190.
53. Panel on Prevention of Falls in Older Persons AGS/ BGS (2010) Summary of the Updated American Geriatrics Society/British Geriatrics Society Clinical Practice Guideline for Prevention of Falls in Older Persons. Journal of the American Geriatrics Society 59, 148-157.
54. Kupferschmidt, K. (2012) Uncertain verdict as vitamin D goes on trial. Science 337, 1476-1478.
55. Bischoff-Ferrari, H.A., Dietrich, T., Orav, E.J., Hu, F.B., Zhang, Y., Karlson, E.W. and Dawson-Hughes, B. (2004) Higher 25-hydroxyvitamin D concentrations are associated with better lower-extremity function in both active and inactive persons aged > or =60 y. Am. J. Clin. Nutr. 80, 752-758.
56. Pfeifer, M., Begerow, B., Minne, H.W., Abrams, C., Nachtigall, D. and Hansen, C. (2000) Effects of a short-term vitamin D and calcium supplementation on body sway and secondary hyperparathyroidism in elderly women. J. Bone Miner. Res. 15, 1113-1118.
57. Pfeifer, M., Begerow, B., Minne, H.W., Suppan, K., Fahrleitner-Pammer, A. and Dobnig, H. (2009) Effects of a long-term vitamin D and calcium supplementation on falls and parameters of muscle function in community-dwelling older individuals. Osteoporos. Int. 20, 315-322.
58. Bischoff-Ferrari, H.A., Dawson-Hughes, B., Staehelin, H.B., Orav, J.E., Stuck, A.E., Theiler, R., Wong, J.B., Egli, A., Kiel, D.P. and Henschkowski, J. (2009) Fall prevention with supplemental and active forms of vitamin D: a meta-analysis of randomised controlled trials. BMJ 339, b3692.
59. Bischoff-Ferrari, H.A., Dietrich, T., Orav, E.J. and Dawson-Hughes, B. (2004) Positive association between 25-hydroxy vitamin D levels and bone mineral density: a population-based study of younger and older adults. Am. J. Med. 116, 634-639.
60. Wicherts, I.S., van Schoor, N.M., Boeke, A.J., Visser, M., Deeg, D.J., Smit, J., Knol, D.L. and Lips, P. (2007) Vitamin D status predicts physical performance and its decline in older persons. J. Clin. Endocrinol. Metab. 92, 2058-2065.
61. Bischoff-Ferrari, H.A., Dawson-Hughes, B., Willett, W.C., Staehelin, H.B., Bazemore, M.G., Zee, R.Y. and Wong, J.B. (2004) Effect of Vitamin D on falls: a meta-analysis. JAMA 291, 1999-2006.
62. Snijder, M.B., van Schoor, N.M., Pluijm, S.M., van Dam, R.M., Visser, M. and Lips, P. (2006) Vitamin D status in relation to one-year risk of recurrent falling in older men and women. J. Clin. Endocrinol. Metab. 91, 2980-2985.
63. Murad, M.H., Elamin, K.B., Abu Elnour, N.O. et al. (2011) Clinical review: The effect of vitamin D on falls: a systematic review and meta-analysis. J. Clin. Endocrinol. Metab. 96, 2997-3006.
64. Brouwer-Brolsma, E.M., Bischoff-Ferrari, H.A., Bouillon, R. et al. (2013) Vitamin D: do we get enough? A discussion between vitamin D experts in order to make a step towards the harmonisation of dietary reference intakes for vitamin D across Europe. Osteoporos. Int. 24, 1567-1577.
65. Heaney, R.P. (2012) Vitamin D-baseline status and effective dose. N. Engl. J. Med. 367, 77-78.
66. Dawson-Hughes, B. (2013) What is the optimal dietary intake of vitamin D for reducing fracture risk? Calcif. Tissue Int. 92, 184-190.
67. Bischoff-Ferrari, H.A., Willett, W.C., Orav, E.J. et al. (2012) A pooled analysis of vitamin D dose requirements for fracture prevention. N. Engl. J. Med. 367, 40-49.
68. EFSA (2011) Scientific Opinion on the substantiation of a health claim related to vitamin D and risk of falling pursuant to Article 14 of Regulation (EC) No 1924/2006 http://wwwefsaeuropaeu/en/efsajournal/pub/2382htm
69. Wacker, M. and Holick, M.F. (2013) Vitamin D - effects on skeletal and extraskeletal health and the need for supplementation. Nutrients 5, 111-148.
70. Giovannucci, E., Liu, Y., Hollis, B.W. and Rimm, E.B. (2008) 25-hydroxyvitamin D and risk of myocardial infarction in men: a prospective study. Arch. Intern. Med. 168, 1174-1180.
71. Zittermann, A., Gummert, J.F. and Borgermann, J. (2011) The role of vitamin D in dyslipidemia and cardiovascular disease. Curr. Pharm. Des. 17, 933-942.
72. Judd, S.E. and Tangpricha, V. (2009) Vitamin D deficiency and risk for cardiovascular disease. Am. J. Med. Sci. 338, 40-44.
73. Anderson, J.L., May, H.T., Horne, B.D., Bair, T.L., Hall, N.L., Carlquist, J.F., Lappe, D.L. and Muhlestein, J.B. (2010) Relation of vitamin D deficiency to cardiovascular risk factors, disease status, and incident events in a general healthcare population. Am. J. Cardiol. 106, 963-968.
74. Forman, J.P., Giovannucci, E., Holmes, M.D., Bischoff-Ferrari, H.A., Tworoger, S.S., Willett, W.C. and Curhan, G.C. (2007) Plasma 25-hydroxyvitamin D levels and risk of incident hypertension. Hypertension 49, 1063-1069.
75. Pilz, S., Tomaschitz, A., Ritz, E. and Pieber, T.R. (2009) Vitamin D status and arterial hypertension: a systematic review. Nat. Rev. Cardiol. 6, 621-630.
76. Holick, M.F. (2004) Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am. J. Clin. Nutr. 80, 1678S-1688S.
77. Baeke, F., Takiishi, T., Korf, H., Gysemans, C. and Mathieu, C. (2010) Vitamin D: modulator of the immune system. Curr. Opin. Pharmacol. 10, 482-496.
78. Cannell, J.J., Vieth, R., Umhau, J.C., Holick, M.F., Grant, W.B., Madronich, S., Garland, C.F. and Giovannucci, E. (2006) Epidemic influenza and vitamin D. Epidemiol. Infect. 134, 1129-1140.
79. Hypponen, E., Laara, E., Reunanen, A., Jarvelin, M.R. and Virtanen, S.M. (2001) Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study. Lancet 358, 1500-1503.
80. Zipitis, C.S. and Akobeng, A.K. (2008) Vitamin D supplementation in early childhood and risk of type 1 diabetes: a systematic review and meta-analysis. Arch. Dis. Child. 93, 512-517.
81. Smolders, J., Menheere, P., Thewissen, M., Peelen, E., Tervaert, J.W.C., Hupperts, R. and Damoiseaux, J. (2010) Regulatory T cell function correlates with serum 25-hydroxyvitamin D, but not with 1,25-dihydroxyvitamin D, parathyroid hormone and calcium levels in patients with relapsing remitting multiple sclerosis. Journal of Steroid Biochemistry and Molecular Biology 121, 243-246.
82. Munger, K.L., Levin, L.I., Hollis, B.W., Howard, N.S. and Ascherio, A. (2006) Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. Journal of the American Medical Association 296, 2832-2838.
83. Mohr, S.B., Garland, C.F., Gorham, E.D. and Garland, F.C. (2008) The association between ultraviolet B irradiance, vitamin D status and incidence rates of type 1 diabetes in 51 regions worldwide. Diabetologia 51, 1391-1398.
84. Urashima, M., Segawa, T., Okazaki, M., Kurihara, M., Wada, Y. and Ida, H. (2010) Randomized trial of vitamin D supplementation to prevent seasonal influenza A in schoolchildren. Am. J. Clin. Nutr. 91, 1255-1260.
85. Laaksi, I., Ruohola, J.P., Mattila, V., Auvinen, A., Ylikomi, T. and Pihlajamaki, H. (2010) Vitamin D supplementation for the prevention of acute respiratory tract infection: a randomized, double-blinded trial among young Finnish men. J. Infect. Dis. 202, 809-814.
86. Nnoaham, K.E. and Clarke, A. (2008) Low serum vita min D levels and tuberculosis: a systematic review and meta-analysis. Int. J. Epidemiol. 37, 113-119.
87. Liu, N., Kaplan, A.T., Low, J., Nguyen, L., Liu, G.Y., Equils, O. and Hewison, M. (2009) Vitamin D induces innate antibacterial responses in human trophoblasts via an intracrine pathway. Biol. Reprod. 80, 398-406.
88. Canning, M.O., Grotenhuis, K., de Wit, H., Ruwhof, C. and Drexhage, H.A. (2001) 1-alpha,25-Dihydroxyvitamin D3 (1,25(OH)(2)D(3)) hampers the maturation of fully active immature dendritic cells from monocytes. Eur. J. Endocrinol. 145, 351-357.
89. Martineau, A.R., Honecker, F.U., Wilkinson, R.J. and Griffiths, C.J. (2007) Vitamin D in the treatment of pulmonary tuberculosis. J. Steroid Biochem. Mol. Biol. 103, 793-798.
90. Dobnig, H., Pilz, S., Scharnagl, H., Renner, W., Seelhorst, U., Wellnitz, B., Kinkeldei, J., Boehm, B.O., Weihrauch, G. and Maerz, W. (2008) Independent association of low serum 25-hydroxyvitamin d and 1,25-dihydroxyvitamin d levels with all-cause and cardiovascular mortality. Arch. Intern. Med. 168, 1340-1349.
91. Ginde, A.A., Scragg, R., Schwartz, R.S. and Camargo, C.A., Jr. (2009) Prospective study of serum 25-hydroxyvitamin D level, cardiovascular disease mortality, and all-cause mortality in older U.S. adults. J. Am. Geriatr. Soc. 57, 1595-1603.
92. Michaelsson, K., Baron, J.A., Snellman, G., et al. (2010) Plasma vitamin D and mortality in older men: a community-based prospective cohort study. Am. J. Clin. Nutr. 92, 841-848.
93. Tuohimaa, P. (2009) Vitamin D and aging. J. Steroid Biochem. Mol. Biol. 114, 78-84.
94. Heaney, R.P. (2008) Vitamin D: criteria for safety and efficacy. Nutr. Rev. 66, S178-181.
95. Vieth, R. (2007) Vitamin D toxicity, policy, and science. J. Bone Miner. Res. 22 Suppl 2, V64-68.
96. Glade, M.J. (2012) A 21st century evaluation of the safety of oral vitamin D. Nutrition 28, 344-356.
97. Hathcock, J.N., Shao, A., Vieth, R. and Heaney, R. (2007) Risk assessment for vitamin D. Am. J. Clin. Nutr. 85, 6-18.
98. (2012) European Food Safety Authorities (EFSA) reevaluated Tolerable Upper Intake Levels (ULs) http:// www.efsa.europa.eu/en/efsajournal/pub/2813.htm